YBR255C-A Antibody

Shipped with Ice Packs
In Stock

Description

Target Protein Overview

Protein Name: Rcf3 (Respiratory supercomplex factor 3)
Gene: YBR255C-A
UniProt ID: Q3E776
Molecular Weight: ~13.7 kDa
Localization: Mitochondrial inner membrane
Function:

  • Modulates oxygen flux through respiratory chain supercomplexes (III₂-IV₂)

  • Associates with monomeric cytochrome c oxidase and supercomplexes

  • Shares homology with the N-terminal region of Rcf2

Role in Respiratory Supercomplex Regulation

  • Rcf3 deletion (rcf3Δ) increases oxygen flux through CIV by up to 25% without affecting growth on non-fermentable media .

  • Co-localizes with mitochondrial markers (MitoTracker) and associates with CIV-containing supercomplexes .

  • Works redundantly with Rcf2; double deletion (rcf2Δ/rcf3Δ) exacerbates defects in cytochrome c oxidase activity .

Functional Interactions

Interaction PartnerRole
Cytochrome c oxidaseStabilizes active conformation of CIV under high ATP demand
Rcf1/Rcf2Forms a regulatory network for supercomplex III₂-IV₂ assembly
MICOS complexIndirect association via cristae morphology modulation (inferred)

Experimental Applications

The YBR255C-A antibody has been utilized in:

  1. Subcellular Localization Studies: GFP-tagged Rcf3 confirmed mitochondrial localization via fluorescence microscopy .

  2. Supercomplex Profiling: Immunoprecipitation-MS identified Rcf3 in CIV-containing supercomplexes .

  3. Quantitative Proteomics: Detected ~1,990 ± 1,107 copies/cell under standard growth conditions .

Research Limitations

  • No GO annotations available for YBR255C-A in BioGRID .

  • Functional redundancy with Rcf2 complicates phenotype isolation in single-gene deletions .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YBR255C-A; Uncharacterized protein YBR255C-A
Target Names
YBR255C-A
Uniprot No.

Target Background

Gene References Into Functions
The study investigates the maturation of Rcf2 into an N- and C-terminal peptide. It demonstrates that the previously uncharacterized Rcf3 (YBR255c-A) is homologous to the N-terminal Rcf2 peptide, while Rcf1 is homologous to the C-terminal portion. Both Rcf3 and the C-terminal fragment of Rcf2 associate with monomeric cytochrome c oxidase and respiratory chain supercomplexes. PMID: 27662906
Database Links
Subcellular Location
Membrane; Single-pass membrane protein.

Q&A

What is YBR255C-A and what is its significance in mitochondrial research?

YBR255C-A (also known as Rcf3) is a gene in the yeast Saccharomyces cerevisiae that encodes a mitochondrial protein associated with respiratory chain supercomplexes. The YBR255C-A gene product was identified through proteomic analysis as a yeast mitochondrial membrane protein but was not initially characterized in detail . Subsequent research established its relationship to respiratory supercomplex factors, particularly as a homolog of the N-terminal portion of Rcf2 .

Methodologically, identification of YBR255C-A/Rcf3 typically involves:

  • Sequence analysis to identify homology with other proteins

  • Subcellular fractionation to isolate mitochondrial proteins

  • Proteomic analysis using mass spectrometry

  • Functional genomics approaches to determine association with respiratory chain components

YBR255C-A's significance lies in its role regulating mitochondrial respiratory function, making it an important target for understanding fundamental aspects of cellular energy metabolism.

How is YBR255C-A/Rcf3 localized within cells and what is its predicted structure?

YBR255C-A/Rcf3 shows exclusive localization to mitochondria, specifically in the inner mitochondrial membrane. This localization has been experimentally verified through fluorescence microscopy of living cells expressing Rcf3-GFP fusion proteins, which show co-localization with MitoTracker staining of mitochondria .

Computer-based analyses of the primary sequence of Rcf3 predict two transmembrane segments within the protein . This suggests Rcf3 is an integral membrane protein with domains that interact with respiratory chain components.

Methodologically, researchers determine localization through:

  • Creation of GFP fusion proteins expressed from authentic chromosomal loci

  • Live-cell fluorescence microscopy with mitochondrial co-staining

  • Subcellular fractionation followed by Western blotting

  • Protease protection assays to determine membrane topology

What is the relationship between YBR255C-A/Rcf3 and other respiratory supercomplex factors?

YBR255C-A/Rcf3 shares significant homology with the N-terminal region of Rcf2, while Rcf1 is homologous to the C-terminal portion of Rcf2 . This structural relationship suggests that Rcf2 may have evolved through fusion of ancestral proteins resembling Rcf3 and Rcf1.

The three proteins have overlapping but distinct roles in respiratory chain function:

  • Rcf1 primarily modulates cytochrome c oxidase activity, maintaining the dominant population in a functionally active state

  • Rcf2 undergoes maturation into an N- and C-terminal peptide

  • Rcf3 (YBR255C-A) associates with supercomplexes predominantly via complex IV

Experimental approaches to study these relationships include sequence analysis, functional complementation studies, and phenotypic analysis of single and multiple gene deletion strains.

What techniques are effective for detecting and studying YBR255C-A/Rcf3 expression?

Several complementary techniques have proven effective for detecting and studying YBR255C-A/Rcf3:

  • Fluorescence microscopy: GFP fusion proteins have successfully visualized Rcf3 localization in mitochondria

  • Western blotting: Affinity capture-Western techniques have demonstrated interactions between YBR255C-A and other proteins

  • Blue Native PAGE (BN-PAGE): Effective for analyzing association with respiratory chain supercomplexes

  • Mass spectrometry: For identification and quantification in complex mitochondrial samples

Methodological considerations when working with YBR255C-A include:

  • Selection of appropriate detergents for solubilization that maintain native interactions

  • Use of proper controls (knockout strains) for antibody validation

  • Careful preparation of mitochondrial fractions to preserve supercomplex integrity

How can protein-protein interactions of YBR255C-A/Rcf3 be effectively characterized?

Affinity Capture-Western has been successfully used to demonstrate the interaction between YBR255C-A and Rcf1 . This technique involves:

  • Affinity capture of bait proteins from cell extracts using antibodies or epitope tags

  • Identification of interaction partners by Western blot analysis

  • Verification using specific antibodies or secondary epitope tags

Additional approaches for characterizing YBR255C-A interactions include:

  • Co-immunoprecipitation with mitochondrial components

  • Crosslinking mass spectrometry to identify interaction interfaces

  • Proximity labeling techniques (BioID, APEX) to identify proteins in the vicinity

  • Two-dimensional electrophoresis to analyze complex composition

Proper experimental design should include appropriate controls and consideration of detergent conditions that preserve native interactions.

What genetic manipulation strategies are most useful for studying YBR255C-A/Rcf3 function?

Several genetic approaches have been successfully employed for YBR255C-A/Rcf3 research:

  • Gene deletion: Single deletion (rcf3Δ) and double deletion with Rcf2 (rcf2Δ/rcf3Δ) have revealed functional redundancy between these proteins

  • Epitope tagging: C-terminal GFP tagging has been used to visualize Rcf3 localization while preserving function

  • Expression from natural loci: Expression of tagged proteins from authentic chromosomal loci maintains natural expression patterns

Methodological considerations for genetic manipulations include:

  • Assessment of tag effects on protein function

  • Verification of correct integration and expression

  • Use of appropriate promoters to maintain physiological expression levels

  • Creation of conditional alleles for essential functions

What phenotypes are observed in YBR255C-A/Rcf3 deletion strains?

Deletion of YBR255C-A/Rcf3 produces specific phenotypes related to mitochondrial function:

  • Increased oxygen flux through complex IV (cytochrome c oxidase)

  • No growth defect on non-fermentable medium, indicating functional respiration is maintained

  • More pronounced effects in double deletion strains (rcf2Δ/rcf3Δ) compared to single deletions, suggesting functional redundancy

These observations suggest YBR255C-A/Rcf3 plays a regulatory role in controlling electron transfer efficiency rather than being absolutely required for supercomplex formation.

Methodological approaches for phenotypic analysis typically include:

  • Growth assays on fermentable versus non-fermentable carbon sources

  • Oxygen consumption measurements using respirometry

  • Spectroscopic analysis of cytochrome spectra

  • Blue native gel electrophoresis to assess supercomplex assembly

How does YBR255C-A/Rcf3 contribute to respiratory supercomplex assembly and dynamics?

YBR255C-A/Rcf3 associates with respiratory chain supercomplexes, predominantly via complex IV (cytochrome c oxidase) . Both Rcf3 and the C-terminal fragment of Rcf2 associate with monomeric cytochrome c oxidase and respiratory chain supercomplexes .

The contribution of YBR255C-A/Rcf3 to supercomplex assembly appears to be regulatory rather than structural. Its deletion increases oxygen flux through the respiratory chain without disrupting supercomplex formation entirely , suggesting a role in fine-tuning electron transfer efficiency.

Experimental approaches to investigate supercomplex dynamics include:

  • Blue native PAGE analysis of digitonin-solubilized mitochondria

  • In-gel activity assays for respiratory complexes

  • Kinetic analysis of respiratory chain activity

  • Crosslinking studies to identify interaction interfaces

What is known about the mechanisms by which YBR255C-A/Rcf3 regulates cytochrome c oxidase?

YBR255C-A/Rcf3 influences the activity of cytochrome c oxidase, as evidenced by increased oxygen flux in deletion strains . This suggests it may modulate the enzyme's catalytic efficiency or regulate electron transfer between respiratory complexes.

While the precise mechanism remains to be fully elucidated, studies on the related protein Rcf1 provide insight into possible regulatory mechanisms. Rcf1 has been shown to maintain cytochrome c oxidase in a functionally active state, especially under high respiratory chain workload . Cytochrome c oxidase exists in three structurally different populations, and Rcf1 maintains the dominant population in a functionally active state .

Given the relationship between YBR255C-A/Rcf3 and other Rcf proteins, it likely contributes to similar regulatory processes, potentially affecting different populations or functional states of cytochrome c oxidase.

How can researchers experimentally differentiate between the functions of Rcf1, Rcf2, and Rcf3 (YBR255C-A)?

Differentiating between the functions of these related proteins requires sophisticated experimental approaches:

  • Comparative phenotypic analysis: Systematic characterization of single, double, and triple deletion strains under various conditions

  • Domain swapping experiments: Creation of chimeric proteins containing domains from different Rcf proteins to map functional regions

  • Complementation studies: Testing whether expression of one protein can rescue phenotypes caused by deletion of another

  • Structural analysis: Using the homology relationship between these proteins (Rcf3 resembles Rcf2's N-terminus; Rcf1 resembles Rcf2's C-terminus) to investigate structure-function relationships

  • Differential interaction mapping: Identifying unique binding partners for each protein

Current research indicates distinct but overlapping roles:

  • Rcf1 primarily modulates cytochrome c oxidase activity

  • Rcf2 undergoes maturation into N- and C-terminal peptides with distinct functions

  • Rcf3 (YBR255C-A) has an overlapping role with Rcf2, particularly in regulating oxygen flux through complex IV

What challenges exist in designing antibodies specific to YBR255C-A/Rcf3 and how can they be addressed?

Developing specific antibodies against YBR255C-A/Rcf3 presents several technical challenges:

  • Limited epitope selection: The protein's small size and transmembrane domains restrict accessible, immunogenic regions

  • Cross-reactivity concerns: Sequence homology with Rcf2's N-terminal region increases the risk of antibody cross-reactivity

  • Validation challenges: Confirming specificity requires careful controls including knockout strains

Methodological approaches to address these challenges include:

  • Epitope selection strategies:

    • Target unique regions that differ from Rcf2

    • Use peptide immunogens from hydrophilic regions

    • Consider recombinant fragments expressed in bacterial systems

  • Validation protocols:

    • Western blot analysis comparing wild-type and rcf3Δ strains

    • Cross-reactivity testing against purified Rcf1 and Rcf2

    • Pre-absorption tests with immunizing peptides

    • Immunoprecipitation followed by mass spectrometry

  • Alternative approaches:

    • Epitope tagging strategies (HA, FLAG) when antibodies prove challenging

    • Using fluorescent protein fusions for localization studies

How can researchers design experiments to elucidate potential post-translational modifications of YBR255C-A/Rcf3?

Investigating post-translational modifications (PTMs) of YBR255C-A/Rcf3 requires specialized approaches:

  • Mass spectrometry-based proteomics:

    • Enrichment strategies for specific modifications (phosphorylation, acetylation)

    • High-resolution MS/MS for precise mapping of modification sites

    • Quantitative approaches to determine stoichiometry of modifications

  • Site-directed mutagenesis:

    • Mutation of potential modification sites to non-modifiable residues

    • Creation of phosphomimetic mutations to simulate constitutive modification

    • Assessment of functional consequences through phenotypic analysis

  • In vitro modification assays:

    • Testing candidate modifying enzymes with purified YBR255C-A/Rcf3

    • Reconstitution experiments with modified and unmodified protein

  • Temporal analysis:

    • Investigation of modification patterns under different metabolic conditions

    • Stress response analysis to identify regulatory modifications

Special considerations for YBR255C-A/Rcf3 include:

  • The relationship to Rcf2 maturation, which involves processing into N- and C-terminal peptides

  • Potential regulatory modifications that might influence interactions with respiratory complexes

  • Modification-dependent conformational changes that could affect function

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.